BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15615858)

  • 1. Antibody buffering of a ligand in vivo.
    O'Hear CE; Foote J
    Proc Natl Acad Sci U S A; 2005 Jan; 102(1):40-4. PubMed ID: 15615858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fine-specificity of the immune response to oxazolone. I. Contact sensitivity and early antibodies.
    Ferreira AM; Hurme M; Kaartinen M; Mäkelä O
    J Immunol; 1981 Dec; 127(6):2366-71. PubMed ID: 7299129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contact sensitization to oxazolone: involvement of both interferon-gamma and interleukin-4 in oxazolone-specific Ig and T-cell responses.
    Thomson JA; Troutt AB; Kelso A
    Immunology; 1993 Feb; 78(2):185-92. PubMed ID: 8473011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-oxazolone hybridomas and strain distribution of the oxazolone idiotype.
    McKimm-Breschkin JL; Breschkin AM
    Scand J Immunol; 1983 Nov; 18(5):421-7. PubMed ID: 6606221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody buffering in the brain.
    O'Hear C; Foote J
    J Mol Biol; 2006 Dec; 364(5):1003-9. PubMed ID: 17045608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic maturation of an immune response.
    Foote J; Milstein C
    Nature; 1991 Aug; 352(6335):530-2. PubMed ID: 1907716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody buffering of systemically administered lysozyme.
    O'Hear C; Foote J
    Eur J Haematol; 2010 Mar; 84(3):252-8. PubMed ID: 19922461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The range and fine specificity of the anti-hapten immune response: phylogenetic studies.
    Litman GW; Stolen JS; Sarvas HO; Mäkelä O
    J Immunogenet; 1982 Dec; 9(6):465-74. PubMed ID: 7161509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo cimetidine immunomodulatory effects on the cutaneous reaction to oxazolone in the chicken.
    Bellavia A; Bannera AF; Marino V; Arcoleo V; Ferrara D
    Immunopharmacology; 1997 Oct; 37(2-3):269-76. PubMed ID: 9403346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fine-specificity of the immune response to oxazolones. IV. Furyloxazolone-specific cytolytic T lymphocytes (unlike antibodies) are not heteroclitic.
    Matoso-Ferreira A
    Immunology; 1984 Nov; 53(3):451-6. PubMed ID: 6333383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient secretion of murine Fab fragments by Escherichia coli is determined by the first constant domain of the heavy chain.
    Alfthan K; Takkinen K; Sizmann D; Seppälä I; Immonen T; Vanne L; Keränen S; Kaartinen M; Knowles JK; Teeri TT
    Gene; 1993 Jun; 128(2):203-9. PubMed ID: 8514187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural implications of somatic mutations during the immune response to 2-phenyloxazolone.
    Spinelli S; Alzari PM
    Res Immunol; 1994 Jan; 145(1):41-5. PubMed ID: 7516564
    [No Abstract]   [Full Text] [Related]  

  • 13. Properties of a single-chain antibody containing different linker peptides.
    Alfthan K; Takkinen K; Sizmann D; Söderlund H; Teeri TT
    Protein Eng; 1995 Jul; 8(7):725-31. PubMed ID: 8577701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo.
    Pardridge WM; Buciak JL; Friden PM
    J Pharmacol Exp Ther; 1991 Oct; 259(1):66-70. PubMed ID: 1920136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional structure determination of an anti-2-phenyloxazolone antibody: the role of somatic mutation and heavy/light chain pairing in the maturation of an immune response.
    Alzari PM; Spinelli S; Mariuzza RA; Boulot G; Poljak RJ; Jarvis JM; Milstein C
    EMBO J; 1990 Dec; 9(12):3807-14. PubMed ID: 2123450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance to heart and kidney grafts induced by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) versus depleting anti-CD4 monoclonal antibody (OX-38) with donor antigen administration.
    Motoyama K; Arima T; Lehmann M; Flye MW
    Surgery; 1997 Aug; 122(2):213-9; discussion 219-20. PubMed ID: 9288125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Map position of Igh-Oxa gene within the Igh region of the DBA/2 mouse strain.
    Pelkonen J; Karjalainen K; Mäkelä O; Taylor BA
    J Immunol; 1982 Jul; 129(1):242-4. PubMed ID: 6806360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variable region primary structures of a high affinity anti-fluorescein immunoglobulin M cryoglobulin exhibiting oxazolone cross-reactivity.
    Dombrink-Kurtzman MA; Johnson LS; Riordan GS; Bedzyk WD; Voss EW
    J Biol Chem; 1989 Mar; 264(8):4513-22. PubMed ID: 2494173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44-mediated neutrophil apoptosis in the rat.
    Takazoe K; Tesch GH; Hill PA; Hurst LA; Jun Z; Lan HY; Atkins RC; Nikolic-Paterson DJ
    Kidney Int; 2000 Nov; 58(5):1920-30. PubMed ID: 11044212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cross-reaction patterns of the MRC OX-3, OX-6, and OX-17 monoclonal antibodies on rat inbred and congenic strains.
    Otová B; Kren V; Bukovský A; Pospíchalová J
    Folia Biol (Praha); 1987; 33(5):363-6. PubMed ID: 3319704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.